Your weekly roundup of the latest news from Drug Topics®.
Although investigators found a lack of strong evidence to support CGM programs in community pharmacy settings, studies in ambulatory care settings suggest that these programs are both feasible and beneficial.
A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.
Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.
LIB Therapeutics released data from the LIBerate-HeFH trial that showed lerodalcibep achieved statistically significant placebo adjusted reductions in mean LDL-C at Week 24 and at the mean of Weeks 22 and 24.
Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?